Roivan­t's JAK/TYK2 in­hibitor fails PhII lu­pus study

Last year
R&D

Arv­inas gets $350M boost from in­vestors to ex­tend run­way in­to 2027

Last year
Financing

So­sei Hep­tares to take back GPCR ag­o­nist af­ter GSK changes course

Last year
Deals

Tang’s Con­cen­tra faces off with Fore­site, Or­biMed in buy­out bat­tle for strug­gling biotech The­seus

Last year
Deals

Ex­clu­sive: Ae­glea re­brands to Spyre, names new CEO in IBD race against TL1A drugs at Mer­ck, Roche and Sanofi

Last year
People

No­vo Nordisk in­vests $2.4B in French fa­cil­i­ty to ad­dress boom­ing GLP-1 de­mand

Last year
Manufacturing

Af­ter pulling Blenrep from US mar­kets, GSK plots a come­back with PhI­II mul­ti­ple myelo­ma tri­al suc­cess

Last year
R&D

Sanofi, Re­gen­eron say Dupix­ent suc­ceeds in an­oth­er late-stage COPD study, set­ting up fil­ing for FDA ap­proval

Last year
R&D
Pharma

Mer­ck­'s neu­ro-in­spired buy­out; Bay­er's bad week; One launch, one shut­down for Flag­ship; and more

Last year
Weekly

FDA warns Genen­tech clin­i­cal in­ves­ti­ga­tor work­ing on pre­ven­tive flu an­tivi­ral tri­al

Last year
FDA+

Ab­b­Vie sues five gener­ic com­pa­nies over po­ten­tial Rin­voq com­peti­tors

Last year
Pharma
Law

Re­ci­pharm to change CEOs, spin out in­haler busi­ness

Last year
Manufacturing

US In­ter­na­tion­al Trade Com­mis­sion takes on Eli Lil­ly's tirzepatide case

Last year
Pharma
Law

Boehringer ac­quires Uni­ver­si­ty of Basel spin­out for $507M to de­vel­op im­munother­a­pies

Last year
Deals
Pharma

Bay­er’s turn­around plan: Fo­cus on spe­cial­ty drugs, low­er costs and few­er big bets

Last year
Pharma

Syn­cona buys gene ther­a­py com­pa­ny; Ory­zon’s €45M fi­nanc­ing agree­ment; In­Dex scraps PhI­II drug

Last year
News Briefing

En­trada's Duchenne study re­mains on hold in US as biotech com­pletes dos­ing of two co­horts in UK tri­al

Last year
R&D

Khosla Ven­tures leads $38M seed round for organoid start­up Vivo­dyne

Last year
Financing
AI

Dai­ichi's long feud with In­di­an bil­lion­aire broth­ers now in­volves law­suit seek­ing $131M dam­ages

Last year
Pharma
Law

Flag­ship-found­ed Evelo Bio­sciences will dis­solve af­ter find­ing no 'vi­able al­ter­na­tive'

Last year
People
R&D

FDA warns Cipla's al­buterol in­haler plant af­ter thou­sands of com­plaints

Last year
R&D
FDA+

Texas at­tor­ney gen­er­al sues Pfiz­er, Tris Phar­ma over man­u­fac­tur­ing is­sues sur­round­ing AD­HD med

Last year
Pharma
Law

Im­prop­er Or­ange Book list­ings harm com­pe­ti­tion, FTC says in am­i­cus brief to an­titrust suit

Last year
Pharma
FDA+

Eu­rope re­vokes one of Mod­er­na's Covid vac­cine patents fol­low­ing op­po­si­tion from BioN­Tech, Pfiz­er

Last year
Pharma
First page Previous page 241242243244245246247 Next page Last page
A service from the Financial Times